Catch up on recent podcasts and webinars featuring FLCCC doctors and advisors and make sure to share your favorites!

Frances was able to advise her son when he developed serious heart problems because she had been following the FLCCC and reading their protocols for a few years. It worked, and her son is back playing sports.

Bryanna has attended the last two FLCCC Educational Conferences. For her the vibe, the energy, the approachability of patients, attendees, the speakers, and practitioners is amazing, especially because the whole goal is to pull together and just help the patient get healthy.

When COVID hit South Africa every authority was demanding the population get vaxxed. Being 63, and in the vulnerable category, he almost took the jab. But things weren't adding up. "With the help of your web pages, my wife and I eventually, after prayer, decided to not take the vax. Best decision ever!"

Dr. Kory digs into the latest designed-to-fail ivermectin study, the "Principle Trial". Was the latest ivermectin takedown successful? Tune in!

Early treatment success! Maureen explains why she attended the FLCCC Conference and how using ivermectin for treating COVID early ensured her and her family made a swift recovery.

Dr. Paul Marik and Dr. Pierre Kory were joined by special guest Kevin McKernan, CSO and Founder of Medicinal Genomics, for a discussion on DNA contamination and the risks associated with the use of COVID vaccines.

Catherine has never known a time like this for unexpected deaths and onset of new illness. She tells a very sad story about what’s happened to her friends, relatives and acquaintances since they got injected.

Dr. Paul Marik and Scott Marsland FNP-C discuss the clinical aspects of Long COVID and Long Vax, answer audience questions and review recent updates to the I-RECOVER treatment guide.

FLCCC Alliance Chief Medical Officer, Dr. Pierre Kory, joined Jan Jeffcoat on The National Desk (TND) and discussed the lingering effects of Long COVID and Long Vax, and how ivermectin and Low-Dose Naltrexone (LDN) are being used to treat spike-protein induced diseases.